Education
About Us
Working with TipRanks
Follow Us
Insmed (INSM)
NASDAQ:INSM
Total Valuation
Insmed has a market cap or net worth of $12.47B. The enterprise value is $12.24B.
Market Cap$12.47B
Enterprise Value$12.24B
Share Statistics
Insmed has 181.82M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding181.82M
Owened by Insiders1.28%
Owened by Instutions0.40%
Financial Efficiency
Insmed’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -50.68%.
Return on Equity (ROE)-320.20%
Return on Assets (ROA)-45.12%
Return on Invested Capital (ROIC)-50.68%
Return on Capital Employed (ROCE)-50.83%
Revenue Per Employee$286,158.143
Profits Per Employee-$718,939.418
Employee Count1,271
Asset Turnover0.18
Inventory Turnover0.87
Valuation Ratios
The current PE Ratio of Insmed is -12.39. Insmed’s PEG ratio is -2.88.
PE Ratio-12.39
PS Ratio31.14
PB Ratio39.69
Price to Fair Value39.69
Price to FCF-16.05
Price to Operating Cash Flow-16.56
PEG Ratio-2.88
Income Statement
In the last 12 months, Insmed had revenue of $363.71M and earned -$913.77M in profits. Earnings per share was -$5.59.
Revenue$363.71M
Gross Profit$275.44M
Operating Income-$799.99M
Pretax Income-$910.07M
Net Income-$913.77M
EBITDA-848.92M
Earnings Per Share (EPS)-5.59
Cash Flow
In the last 12 months, operating cash flow was -$683.88M and capital expenditures -$21.92M, giving a free cash flow of -$705.80M billion.
Operating Cash Flow-$683.88M
Free Cash Flow-$705.80M
Free Cash Flow per Share-$3.88
Dividends & Yields
Insmed pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-6.23%
Earnings Yield-8.07%
Stock Price Statistics
Beta0.93
52-Week Price Change155.67%
50-Day Moving Average76.67
200-Day Moving Average73.73
Relative Strength Index (RSI)36.27
Average Volume (3m)2.05M
Important Dates
Insmed upcoming earnings date is May 1, 2025, TBA.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 5.45, with Debt / Equity ratio of 0.16
Current Ratio5.45
Quick Ratio5.12
Debt to Market Cap<0.01
Net Debt to EBITDA0.62
Interest Coverage Ratio-10.94
Taxes
In the past 12 months, Insmed has paid $3.71M in taxes.
Income Tax$3.71M
Effective Tax Rate-0.41%
Enterprise Valuation
Insmed EV to EBITDA ratio is -13.21, with an EV/FCF ratio of -15.32.
EV to Sales29.74
EV to EBITDA-13.21
EV to Free Cash Flow-15.32
EV to Operating Cash Flow-15.82
Balance Sheet
Insmed has $1.43B in cash and marketable securities with $45.49M in debt, giving a net cash position of -$1.39B billion.
Cash & Marketable Securities$1.43B
Total Debt$45.49M
Net Cash-$1.39B
Net Cash Per Share-$7.64
Tangible Book Value Per Share$0.55
Margins
Gross margin is 76.43%, with operating margin of -241.47%, and net profit margin of -251.24%.
Gross Margin76.43%
Operating Margin-241.47%
Pretax Margin-250.22%
Net Profit Margin-251.24%
EBITDA Margin-225.12%
EBIT Margin-228.15%
Analyst Forecast
The average price target for Insmed is $98.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$98.00
Price Target Upside42.92%
Analyst ConsensusStrong Buy
Analyst Count15
Revenue Growth Forecast19.17%
EPS Growth Forecast-4.45%